• ArtsandLectures twitter avatar
    RT @SBIndpndnt: Maira Kalman’s Illustrated Life: Legendary Author/Illustrator Extols the Beauty of Not Knowing https://t.co/EFX768LO2w http…
    6 hours 59 min ago
  • ArtsandLectures twitter avatar
    RT @StationCDRKelly: Going around the track @IMS at 180mph in an @IRE2seater seems faster than the #SpaceShuttle! No kidding! https://t.co/…
    10 hours 51 min ago
  • UCSBgauchos twitter avatar
    Women's Soccer: UC Santa Barb. 0, UC Irvine 1 (Final) Gauchos Lose Tough One at UC Irvine, 1-0 https://t.co/7iPDd8IfSb
    12 hours 14 min ago
  • UCSBgauchos twitter avatar
    RT @ucsbtennis: Congrats to Morgan and Simon on taking the doubles title at the Southwest Regional! NYC here we come! #GoGauchos #regionalc
    12 hours 32 min ago
  • UCSBgauchos twitter avatar
    Will the Gauchos climb in rankings after upsetting No. 5 Stanford 7-6? https://t.co/GhYPn3tee4
    16 hours 55 min ago
  • brenucsb twitter avatar
    Attention environmental problem solvers! #BrenUCSB is accepting MESM and PhD applications for Fall 2017. Learn more https://t.co/G4NB6n0Ne4
    18 hours 18 min ago
  • ucsantabarbara twitter avatar
    Congrats to #UCSB physicist Andrea Young for receiving a 2016 Fellowship to pursue his studies! https://t.co/U0VRrjpcVo
    18 hours 48 min ago
  • UCSBgauchos twitter avatar
    WVB: Gauchos Bounce Back, Defeat CSUN 3-1 on Alumni Night https://t.co/FojzbAmgtC
    1 day 4 hours ago
  • UCSBgauchos twitter avatar
    .@UCSBMensSoccer has to settle for draw over rival Cal Poly in front of season-high crowd. RECAP >>>… https://t.co/SWgs9zjRSJ
    1 day 5 hours ago
  • UCSBgauchos twitter avatar
    Attention UCSB fans, https://t.co/DWr6IUf6ek have live stream of postgame presser w/ Tim Vom Steeg. Listen here >>> https://t.co/ERE7yxUmyI
    1 day 8 hours ago
  • UCSBgauchos twitter avatar
    No. 7 UCSB Deal Thrilling Upset to No. 5 Stanford 7-6 https://t.co/cqiTDXJPRn
    1 day 11 hours ago
  • AS_UCSB twitter avatar
    Good luck to @UCSBMensSoccer today taking on the bad guys Cal Poly. Let's get it! #GauchoStrong
    1 day 12 hours ago
  • brenucsb twitter avatar
    What's it like to study at #BrenUCSB? See these students' stories to find out: https://t.co/A0sE88SEwV
    1 day 18 hours ago
  • UCSBgauchos twitter avatar
    Gauchos Push First Place Long Beach St. to the Brink, Fall Just Short in Five https://t.co/7FHfqLwpBh
    2 days 6 hours ago
  • ArtsandLectures twitter avatar
    .@MairaKalman's Illustrated Life: Legendary Author/Artists Extols the Beauty of Not Knowing:… https://t.co/BCa6uiIN7D
    2 days 10 hours ago

A Diet Dividend

Members of the Thomas Weimbs Lab demonstrate that reducing food intake in mice diminishes the growth of their polycystic kidneys
Thursday, January 28, 2016 - 10:00
Santa Barbara, CA

Thomas Weimbs.jpg

Thomas Weimbs

Thomas Weimbs

Photo Credit: 

Sonia Fernandez

What if polycystic kidney disease (PKD) could be combatted with a strategy as simple as dieting? Such a finding would surely be welcome news to the 12 million people worldwide with the genetic disease.

New research from UC Santa Barbara suggests that reducing food intake may slow the growth of the cysts that are symptomatic of PKD, an inherited disorder in which clusters of cysts develop in the kidneys.

A study by biologist Thomas Weimbs and colleagues has demonstrated that in mouse models, a modest decrease in food intake resulted in substantially diminished cyst growth. The findings appear in the American Journal of Physiology - Renal Physiology.

“Amazingly, the growth of polycystic kidneys was quite strongly inhibited with the reduced food intake, suggesting that these organs are much more sensitive to nutrients than the rest of the body,” said Weimbs, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology. “That’s very interesting because if we translate this to a human population, the regimen should be something that would be potentially feasible for PKD patients to follow.”

The researchers were particularly interested in the mTOR pathway, the mechanistic target of a drug called rapamycin, which has been studied as a potential treatment for PKD. When nutrients are abundant, the mTOR pathway — important in regulating cell growth and proliferation — is highly active. So the investigators hypothesized that limiting nutrient supply might affect the pathway’s activity and tested their theory in mice with polycystic kidneys.

Animals in the control group had free access to food and showed a kidney weight increase of 151 percent during the study period. Those in the experimental group, in which food intake was reduced 23 percent, experienced only a 41 percent gain in kidney weight. “That’s pretty substantial,” said Weimbs. “The reduction is similar to what we would see with rapamycin treatment but without the side effects.”

The researchers also looked at other parameters, such as proliferation of the cysts and the inhibition of other molecular pathways. “Not only did the size of cysts decrease significantly but pathways were inhibited as we expected them to be,” Weimbs said. “All of this made sense with our initial hypothesis.”

Moving from animal to human studies, however, would require additional research as well as clinical trials. Still to be determined is whether the sizable effects seen in this study are due to simply decreasing caloric intake or to a reduction in a particular nutrient group, such as carbohydrates, lipids or proteins.

“That’s something we really don’t know, but it’s something that can be easily tested and should be, because potentially we only have to reduce one nutrient group and not all of the others,” Weimbs explained. “Or maybe it’s just the caloric intake. We need to know which before it makes sense to move forward with a clinical trial.”

The results of the Weimbs Lab’s research are similar to another recent study conducted at the Mayo Clinic in Rochester, Minnesota. While that group used slightly different mouse models and a more severe level of food restriction — 40 percent — the results also demonstrated a reduction in cyst growth.

“Two groups using different protocols and different models that come to the same conclusion strengthens the overall findings and makes a clinical trial much more justifiable,” Weimbs concluded.

Contact Info: 

Julie Cohen
(805) 893-7220